Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Thermo Fisher, Bio-Rad, and More

Premium

Thermo Fisher Scientific this week introduced its Thermo Scientific Vanquish UHPLC system, with which the company is targeted the high-end research market.

According to the company, the instrument offers 1,500 bar maximum pump pressure and flow rate up to 5mL per minute. The instrument also features SmartFlow pumping technology for reproducible retention times, both direct heating and forced air temperature controls, and the Chromeleon data system.


Bio-Rad this week launched its Bio-Plex Pro RBM Human Metabolic and Hormone Assays, seven multiplex immunoassay panels to a total of 39 analytes for use in research into metabolic and cardiovascular conditions.


Shimadzu has released its i-Series HPLC systems. The systems feature a new PC-free operating environment, allowing researchers to control them from smart devices and automate workflows from start-up to shutdown after analysis.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more